Welcome to a breakthrough in cancer care with NovoCure, a pioneering approach designed to fight cancer with cutting-edge, non-invasive technology
NovoCure’s therapy provides a unique method to combat cancer by targeting cancer cells’ ability to multiply. Unlike traditional treatments such as chemotherapy or radiation, TTFields therapy uses low-intensity alternating electric fields to interrupt cancer cell division, slowing down or even stopping tumour growth.
TTFields therapy delivers electric fields directly to the tumour site through non-invasive adhesive transducer arrays placed on the skin. These fields interfere with the cell’s structure during division, specifically targeting rapidly dividing cancer cells while sparing healthy ones.
Currently, TTFields therapy is approved for certain hard-to-treat cancers, such as glioblastoma (GBM) and mesothelioma, and is undergoing studies for use in additional cancer types, including lung and pancreatic cancers. As research advances, TTFields therapy holds promise for an expanded range of cancers.
TTFields therapy is non-invasive, meaning no surgery, injections, or major disruptions to daily life. It allows patients to continue their normal activities while benefiting from an effective cancer treatment.
With no radiation or chemotherapy involved, TTFields therapy significantly reduces the risk of side effects typically associated with cancer treatment. Most patients experience only mild skin irritation where the arrays are applied, allowing for a more comfortable treatment experience.
TTFields devices are compact, portable, and wearable, so patients can receive therapy around the clock while moving about freely. This flexibility offers an option to maintain independence, travel, and engage in everyday activities.
NovoCure provides personalised support services to help patients and their families navigate device use, manage skin care, and maintain comfort. From initial setup to ongoing support, patients are fully supported throughout their journey.
NovoCure’s TTFields therapy has shown significant efficacy in clinical trials for certain cancers, particularly glioblastoma. Studies indicate that TTFields therapy can extend survival and improve quality of life for patients, making it a valuable addition to cancer treatment plans.
For many patients, TTFields therapy can be combined with chemotherapy or radiation to enhance treatment effectiveness, providing a multi-faceted approach to cancer care.
Cancer treatment is evolving, and NovoCure’s TTFields therapy is at the forefront of non-invasive, effective cancer care. Discover how this groundbreaking treatment may help you or your loved ones live longer and experience improved quality of life. Take the next step toward innovative cancer care with NovoCure.
Want to know more about our Radiation Technology?
Our friendly staff are here to help you, get in touch with them today.
